UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2020 | 2021-03-08 | Future report Set alerts | |
| Q3 2020 | 2020-11-02 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-10 | 0.29 | 0.29 |
| Q1 2020 | 2020-05-11 | -0.35 | -0.35 |
| Q4 2019 | 2020-03-10 | -0.26 | -0.26 |
| Q3 2019 | 2019-11-04 | -0.22 | -0.22 |
| Q2 2019 | 2019-08-05 | -0.26 | -0.26 |
| Q1 2019 | 2019-05-06 | -0.23 | -0.23 |
| Q4 2018 | 2019-03-11 | -0.21 | -0.21 |
| Q3 2018 | 2018-11-08 | -0.22 | -0.22 |
| 2016-05-19 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-03-14 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-01-07 | Reiterated Rating | Cowen and Company | Market Perform | |
| 2015-09-24 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2015-05-18 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $7.00 to $14.00 |
| 2014-11-06 | Downgrade | Cowen and Company | Outperform to Market Perform | |
| 2014-01-13 | Initiated Coverage | Goldman Sachs | Neutral | $7.00 |
| 2013-12-04 | Downgrade | Citigroup Inc. | Buy to Neutral | |
| 2012-11-14 | Initiated | Stifel Nicolaus | Buy | $16 |
| 2016-05-19 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-03-14 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-01-07 | Reiterated Rating | Cowen and Company | Market Perform | |
| 2015-09-24 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2015-05-18 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $7.00 to $14.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CCXI 161 funds of 2197 total. Show all
| Fund name | Ticker shares |
|---|---|
| FMR LLC | 10.33M |
| WELLINGTON MANAGEMENT CO LLP | 6.70M |
| RA CAPITAL MANAGEMENT, LLC | 4.83M |
| Vanguard Group, Inc | 4.58M |
| BlackRock Inc. | 4.47M |
| STATE STREET CORP | 1.97M |
| Cormorant Asset Management, LLC | 1.65M |
| BlackRock Fund Advisors | 1.41M |
| PICTET ASSET MANAGEMENT LTD | 1.30M |
| WASATCH ADVISORS INC | 1.08M |
| Marshall Wace North America, L.P. | 0.93M |
| BAKER BROS. ADVISORS LP | 0.90M |
| MACQUARIE GROUP LTD | 0.86M |
| D. E. Shaw & Co., Inc. | 0.77M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.75M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Schall Thomas J. President and CEO | 5.04% (2184994) | CCXI / |
| Edwards Thomas A. | 0.32% (138785) | CCXI / |
| LUCAS ROGER C | 0.22% (93846) | CCXI / TECH / |
| FECZKO JOSEPH M | 0.19% (82096) | CCXI / KERX / |
| Bekker Petrus SVP of Medical & Clinical | 0.14% (59839) | CCXI / |
| Tyree James L | 0.12% (53849) | CCXI / DEPO / THRX / |
| Parker Geoffrey M. | 0.11% (45671) | ANAC / CCXI / GHDX / PRGO / SNSS / |
| MCKINNELL HENRY A | 0.10% (44218) | CCXI / MCO / |
| KANAYA SUSAN M SVP, Finance, CFO and Sec. | 0.09% (38135) | CCXI / |
| Jaen Juan C. SVP, Drug Discovery & CSO | 0.07% (30000) | CCXI / |
| Cappel Markus J. Chief Bus. Officer & Treasurer | 0.05% (23826) | CCXI / |
| KLEIN IRA | 0.04% (16216) | CCXI / |
| SINGH RAJINDER SVP, Research | 0.02% (10000) | CCXI / |
Undercovermarket.com